
About Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology is a Healthcare company based in Haidian (China) founded in 2015 by Wenjun Yang. Micro-droplet digital PCR and diagnostic reagents are manufactured. Beijing Xinyi Biotechnology has raised $23.19 million across 3 funding rounds from investors including Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics.
Company details
Beijing Xinyi Biotechnology was founded in 2015 and is based in Haidian, China. Operations focus on the biotechnology sector, where micro-droplet digital PCR systems and in vitro diagnostic reagents are produced. Key products encompass drop makers for sample preparation, chip readers, universal PCR amplification reagents, genetic testing kits for research purposes, micro-droplet detection oil, and nucleic acid extraction reagents using magnetic beads. The domain targetingone.com is associated with the company.
- Headquarters Haidian, China
- Founders Wenjun Yang
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website targetingone.com
- Total Equity Funding$23.19M (USD)
in 3 rounds
- InvestorsLilly Asia Ventures
& 4 more
Funding Insights of Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology has successfully raised a total of $23.19M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.19M
- Total Rounds 3
- Investors Count 5
All 3 funding rounds of Beijing Xinyi Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | Series B | β | Jiuzhi Capital | β | |
| Jan 2021 | $23.19M | Series B | β | Lilly Asia Ventures, China Growth Capital | β |
| Sep 2018 | Seed | β | β |
5 investors in total: 5 institutional.
Investors in Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity investments are managed with long-term focus. | hillhouseinvestment.com | New York, United States | ||
| lillyasiaventures.com | ||||
| chinagrowthcapital.com | ||||
| wonderlandcapital.cn |
Investor details for Beijing Xinyi Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Beijing Xinyi Biotechnology
1 people are tracked at Beijing Xinyi Biotechnology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Wenjun Yang | Co-Founder | Leadership |
Complete people profiles for Beijing Xinyi Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Beijing Xinyi Biotechnology
3 dated milestones of Beijing Xinyi Biotechnology across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Beijing Xinyi Biotechnology is founded.
- Funding First funding round.
- Funding Latest funding round, Series B,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Beijing Xinyi Biotechnology
Complete news archive for Beijing Xinyi Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Beijing Xinyi Biotechnology is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Beijing Xinyi Biotechnology is a funded company, having raised a total of $23.19M across 3 funding rounds to date.
Beijing Xinyi Biotechnology was founded in 2015 and is based in Haidian, China. Operations focus on the biotechnology sector, where micro-droplet digital PCR systems and in vitro diagnostic reagents are produced. Key products encompass drop makers for sample preparation, chip readers, universal PCR amplification reagents, genetic testing kits for research purposes, micro-droplet detection oil, and nucleic acid extraction reagents using magnetic beads. The domain targetingone.com is associated with the company.
Beijing Xinyi Biotechnology has 5 investors. Key investors include Jiuzhi Capital, Lilly Asia Ventures, China Growth Capital, Hillhouse, and Huade Capital Management Group.
